The Management of Hypertension in Pregnancy

References

• Pickering G. High Blood Pressure. J and A Churchill Ltd., London 1968; 1–5
   Google Scholar
• Sheehan H L, Lynch J B. Pathology of Toxaemia in Pregnancy. Churchill Livingstone, London 1973; 524–553
   Google Scholar
• Govan A DT. The pathogenesis of eclamptic lesions. Path Microbiol 1961; 24: 561–575
   PubMedGoogle Scholar
• Chester E M, Agamabolis D P, Banker B Q, et al. Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology 1976; 28: 928–939
   Web of Science ®Google Scholar
• MacKenzie E T, Strandgaard S, Graham D I, et al. Effects of acutely induced hypertension in cats in pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circulation Res 1976; 39: 33–41
   PubMed Web of Science ®Google Scholar
• Goldby F S, Beilin L J. Relationship between arterial pressure and the permeability of arterioles to carbon particles in acute hypertension in the rat. Cardiovascular Res. 1972; 6: 384–390
   PubMed Web of Science ®Google Scholar
• Kaplan N M. Clinical Hypertension. Williams and Wilkins, Baltimore 1978; 160–177
   Google Scholar
• Chesley L C. Hypertensive disorders in pregnancy. Appleton-Century Crofts, New York 1978; 358–371
   Google Scholar
• Sheehan H L, Lynch J B. Pathology of toxaemia of pregnancy. Churchill Livingstone, London 1973; 328–330
   Google Scholar
• Kincaid-Smith P, McMichael J, Murphy E A. The clinical course and pathology of hypertension with papilloedeman (malignant hypertension). Quart J Med 1958; 27: 117–153
   PubMedGoogle Scholar
• Pollack V E, Nettles J B. The kidney in toxemia of pregnancy: a clinical and pathologic study based on renal biopsies. Medicine 1960; 39: 469–526
   PubMed Web of Science ®Google Scholar
• Robson J S, Martin A M, Ruckley V A, et al. Irreversible postpartum renal failure. Quart J Med 1968; 37: 423–435
   PubMedGoogle Scholar
• McKay D G, Merrill S J, Weiner A E, et al. The pathologic anatomy of eclampsia, bilateral renal cortical necrosis, pituitary necrosis, and other acute fatal complications of pregnancy, and its possible relationship to the generalised Shwartzman phenomenon. Am J Obstet Gynecol 1953; 66: 507–539
   PubMed Web of Science ®Google Scholar
• Schwartz M L, Brenner W E. The obfuscation of eclampsia by thrombotic thrombocytopenic purpura. An J Obstet Gynecol 1978; 131: 18–24
   PubMed Web of Science ®Google Scholar
• Pritchard A J, Cunningham F G, Mason R A. Does coagulation have a causative role in eclampsia?. Hypertension in Pregnancy, M D Lindheimer, A I Katz, F P Zuspan. John Wiley, New York 1976; 95–101
   Google Scholar
• Strandgaard S, Olesen J, et al. Autoregulation of brain circulation in severe arterial hypertension. Br Med J 1973; 1: 507–510
   PubMed Web of Science ®Google Scholar
• Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment in the tolerance to acute, drug-induced hypotension. Circulation 1976; 53: 720–727
   PubMed Web of Science ®Google Scholar
• Barry D I, Strandgaard S, Graham D I, et al. Cerebral blood flow in rats with renal and spontaneous hypertension: resetting of the lower limit of auto-regulation. J Cerebral Blood Flow and Metab 1982; 2: 347–353
   PubMed Web of Science ®Google Scholar
• Zuspan F P, O'Shaughnessy R W, Vinsel J, et al. Adrenergic innervation of uterine vasculature in human term pregnancy. Am J Obstet Gynecol 1981; 139: 678–680
   PubMed Web of Science ®Google Scholar
• Wallenburg C S, Hutchinson D L. A radioangiographic study of the effect of catecholamines on uteroplacental blood flow in the rhesus monkey. J Med Primatol 1979; 8: 57–65
   PubMed Web of Science ®Google Scholar
• Blanchard K, Dandavino A, Nuwayhid B, et al. Systemic and uterine hemodynamic responeses to dopamine in pregnant and nonpregnant sheep. Am J Obstet Gynecol 1978; 130: 669–673
   PubMedGoogle Scholar
• Hon E H, Reid B L, Hehre F W. The electronic evaluation of fetal heartrate: II. Changes with maternal hypotension. Am J Obstet Gynecol 1960; 79: 209–215
   PubMed Web of Science ®Google Scholar
• Johnson T, Clayton C G. Diffusion of radioactive sodium in normotensive and pre-eclamptic pregnancies. Br Med J 1957; 1: 312–314
   PubMedGoogle Scholar
• Dixon H G, McClure Browne J C, Davey D A. Choriodecidual and myometrial blood-flow. Lancet 1963; 2: 369–373
   PubMed Web of Science ®Google Scholar
• Lippert T H, Cloeren S E, Fridrich R. Assessment of uteroplacental hemodynamics in complicated pregnancy. Int J Gynaecol Obstet 1979; 16: 274–280
   Google Scholar
• Howard W F, Hunter C A, Huber C P. Intervillous blood oxygen studies. Surg Gynec and Obstet 1961; 112: 435–438
   PubMedGoogle Scholar
• Robertson W B, Brosens I, Dixon H G. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Path Bact 1967; 93: 581–592
   PubMedGoogle Scholar
• Brosens I, Renaer M. On the pathogenesis of placental infarcts in pre-eclampsia. J Obstet Gynaec Br Commonw 1972; 79: 794–799
   PubMedGoogle Scholar
• Moore M P, Redman C WG. Case-control study of severe pre-eclampsia of early onset. Br Med J 1983; 287: 580–583
   PubMed Web of Science ®Google Scholar
• Thomson A M, Billewicz W Z, Hytten F E. The weight of the placenta in relation to birthweight. J Obstet Gynaec Br Commonw 1969; 76: 865–872
   PubMedGoogle Scholar
• Joyce D N, Kenyon V G. The use of diazepam and hydrallazine in the treatment of severe pre-eclampsia. J Obstet Gynaecol Br Commonw 1972; 79: 250–254
   PubMedGoogle Scholar
• Pritchard J A, Pritchard S A. Standardised treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol 1975; 123: 543–549
   PubMed Web of Science ®Google Scholar
• Chamberlain G VP, Lewis P J, de Swiet M, et al. How obstetricians manage hypertension in pregnancy. Br Med J 1978; 1: 626–629
   PubMed Web of Science ®Google Scholar
• Lindberg B S, Sandstrom B. How Swedish obstetricians manage hypertension in pregnancy. A questionnaire study. Acta Obstet Gynecol Scand 1981; 60: 327–331
   PubMed Web of Science ®Google Scholar
• Assali N S, Kaplan S, Oighenstein S, et al. Hemodynamic effects of I-hydrazinophthalazine in human pregnancy; results of intravenous administration. J Clin Invest 1953; 32: 922–930
   PubMed Web of Science ®Google Scholar
• McCall M L. Cerebral circulation and metabolism in toxemia of pregnancy. Observations on the effects of veratrum viride and Apresoline (I-hydrazino-phthalaine). Am J Obstet Gynecol 1953; 66: 1015–1030
   PubMed Web of Science ®Google Scholar
• Barry D I, Paulson O B, Jarden J O, et al. Effects of captopril on cerebral blood flow in normotensive and hypertensive rats. Am J Med 1984, in press
   Web of Science ®Google Scholar
• Overgaard J, Skinhoj E. A paradoxical cerebral hemodynamic effect of hydralazine. Stroke 1975; 6: 402–404
   PubMed Web of Science ®Google Scholar
• Man In't Veld A J, Wenting G J, Venhoeven R M, et al. Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension. Clin Sci 1978; 55(Suppl 4)329–332
   Google Scholar
• Gant N F, Madden J D, Siiteri P K, et al. The metabolic clearance rate of dehydroisoandrosterone sulfate. IV. Acute effects of induced hypertension, hypotension and naturesis in normal and hypertensive pregnancies. Am J Obstet Gynecol 1976; 124: 143–148
   PubMed Web of Science ®Google Scholar
• Vink G J, Moodley J, Philpott R H. Effect of dihydralazine on the fetus in the treatment of maternal hypertension. Obstet Gynecol 1980; 55: 519–522
   PubMed Web of Science ®Google Scholar
• Vink G J, Moodley J. The effect of low-dose dihydrallazine on the fetus in the emergency treatment of hypertension in pregnancy. S Afr Med J 1982; 62: 475–477
   PubMed Web of Science ®Google Scholar
• Lin M-S, McNay J L, Shepherd A MM, et al. Increased plasma norepinephrine accompanies persistent tachycardia after hydralazine. Hypertension 1983; 5: 257–263
   PubMed Web of Science ®Google Scholar
• Neuman J, Weiss B, Rabelloy, et al. Diazoxide for the acute control of severe hypertension complicating pregnancy: a pilot study. Obstet Gynecol 1979; 53: 50–55, Suppl
   PubMed Web of Science ®Google Scholar
• Moms J A, Arce J J, Hamilton C J, et al. The management of severe pre-eclampsia and eclampsia with intravenous diazoxide. Obstet Gynaecol 1977; 49: 675–680
   Web of Science ®Google Scholar
• Pennington J C, Picker R H. Diazoxide and the treatment of the acute hypertensive emergency in obstetrics. Med J Aus 1972; 2: 1051–1054
   PubMedGoogle Scholar
• Michael C A. Intravenous diazoxide in the treatment of severe pre-eclamptic toxaemia and eclampsia. Aus N.Z. J Obstet Gynaecol 1973; 13: 143–146
   PubMed Web of Science ®Google Scholar
• Henrich W L, Cronin R, Miller P D, et al. Hypotensive sequelae of diazoxide and hydralazine therapy. J Am Med Assoc 1977; 237: 264–265
   Web of Science ®Google Scholar
• Ledingham J GG, Rajagopalan B. Cerebral complications in the treatment of accelerated hypertension. Quart J Med 1979; 48: 25–41
   PubMedGoogle Scholar
• MacLean A B, Doig J R, Chatfield W R, et al. Small-dose diazoxide administration in pregnancy. Aust NZ J Obstet Gynaecol 1981; 21: 7–10
   PubMed Web of Science ®Google Scholar
• Ram C VS, Kaplan N M. Individual titration of diazoxide dosage in the treatment of severe hypertension. Am J Cardiology 1979; 43: 627–630
   PubMed Web of Science ®Google Scholar
• Garrett B N, Kaplan N M. Efficacy of slow infusion of diazoxide in the treatment of severe hypertension without organ hypoperfusion. Am Heart J 1982; 103: 390–394
   PubMed Web of Science ®Google Scholar
• Thien Th, Koene R AP, Schijf C L, et al. Infusion of diazoxide in severe hypertension during pregnancy. Eur J Obstet Gynecol Reprod Biol 1980; 10: 367–374
   PubMed Web of Science ®Google Scholar
• Barr P A, Gallery E DM. Effect of diazoxide on the antepartum cardiotocograph in severe pregnancy - associated hypertension. Aust N.Z. J Obstet Gynaecol 1981; 21: 11–15
   PubMed Web of Science ®Google Scholar
• Freis E D. Should mild hypertension be treated?. New Eng J Med 1982; 307: 306–309
   PubMed Web of Science ®Google Scholar
• Pickering G. High Blood Pressure. J and A Churchill Ltd., London 1968; 367–377
   Google Scholar
• Chesley L C, Annitto J E, Jarvis D G. A study of the interaction of pregnancy in hypertensive disease. Am J Obstet Gynecol 1947; 53: 851–863
   PubMed Web of Science ®Google Scholar
• Butler N R, Bonham D G. Toxemia in pregnancy. Perinatal Mortality. E and S Livingstone, Edinburgh 1963; 86–100
   Google Scholar
• Harley J MG. Pregnancy in the chronic hypertensive woman. Proc Roy Soc Med 1966; 39: 835–838
   Google Scholar
• Waiters W AW. Effects of sustained maternal hypertension on fetal growth and survival. Lancet 1966; 2: 1214–1217
   PubMed Web of Science ®Google Scholar
• Sheppard B L, Bonnar J. The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by fetal growth retardation. Br J obstet Gynaecol 1976; 83: 948–959
   PubMedGoogle Scholar
• De Wolf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply of the hyman placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980; 87: 678–685
   PubMedGoogle Scholar
• Abramowsky C R, Vegas M E, Swinehart G, et al. Decidual vasculopathy of the placenta in lupus erythematosus. New Eng J Med 1980; 303: 668–672
   PubMed Web of Science ®Google Scholar
• Brosens I A, Robertson W B, Dixon H G. The role of the spiral arteries in the pathogenesis of pre-eclampsia. Obstetrics and Gynecology Annual, R M Wynn. Appleton-Century-Crofts, New York 1972; 177–191
   Google Scholar
• Brosens I, Dixon H G, Robertson W B. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaec 1977; 84: 656–663
   PubMedGoogle Scholar
• Gerretsen G, Huisjes H J, Elema J D. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynecol 1981; 88: 876–881
   PubMedGoogle Scholar
• Cuadros A, Tatum H J. The prophylactic and therapeutic use of bendroflumethiazide in pregnancy. Am J Obstet Gynecol 1964; 89: 891–897
   PubMed Web of Science ®Google Scholar
• Menzies D N. Controlled trial of chlorothiazide in treatment of early pre-eclampsia. Br Med J 1964; 1: 739–742
   PubMedGoogle Scholar
• Arias F, Zamora J. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol 1979; 53: 489–494
   PubMed Web of Science ®Google Scholar
• Rubin P C, Butters L, Clark D M, et al. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1983; 1: 431–434
   PubMed Web of Science ®Google Scholar
• Weseley A C, Douglas G W. Continuous use of chlorothiazide for prevention of toxemia of pregnancy. Obstet Gynecol 1962; 19: 355–358
   PubMed Web of Science ®Google Scholar
• Landesman R, Aguero O, Wilson K, et al. The prophylactic use of chlorthalidone, a sulfonamide diuretic in pregnancy. J Obstet Gynaec Br Cwlth 1965; 72: 1004–1010
   Google Scholar
• Campbell D M, MacGillivray I. The effect of a low calorie diet or a thiazide diuretic on the incidence of pre-eclampsia and on birthweight. Br J Obstet Gynaecol 1975; 82: 572–577
   PubMedGoogle Scholar
• Kraus G W, Marchese J R, Yen S SC. Prophylactic use of hydrochlorothiazide in pregnancy. J Am Med Assoc 1966; 198: 1150–1154
   Web of Science ®Google Scholar
• Flowers C E, Grizzle J E, Easterling W E, et al. Chlorothiazide as a prophylaxis against toxemia of pregnancy, A double-blind study. Am J Obstet Gynec 1962; 84: 919–929
   PubMed Web of Science ®Google Scholar
• Tervilä L, Vartiaien L. The effects and side effects of diuretics in the prophylaxis of toxaemia of pregnancy. Acta Obstet Gynaecol Scand 1971; 50: 351–356
   PubMed Web of Science ®Google Scholar
• Fallis N E, Plauche W C, Mosey L M, et al. Thiazide versus placebo in prophylaxis of toxemia of pregnancy in primigravid patients. Am J Obstet Gynecol 1964; 88: 502–504
   PubMed Web of Science ®Google Scholar
• Finnerty F A, Bepko F J. Lowering the perinatal mortality and the prematurity rate. J Am Med Assoc 1966; 195: 429–432
   Web of Science ®Google Scholar
• Palomaki J F, Lindheimer M D. Sodium depletion simulating deterioration in a toxemic pregnancy. New Eng J Med 1970; 282: 88–89
   PubMed Web of Science ®Google Scholar
• Gant N F, Madden J D, Siiteri P K, et al. The metabolic clearance rate of dehyroisoandrosterone. III. The effect of thiazide diuretics in normal and future pre-eclamptic pregnancies. Am J Obstet Gynecol 1975; 123: 159–163
   PubMed Web of Science ®Google Scholar
• Minkowitz S, Soloway H, Hall E J, et al. Fatal hemorrhagic pancreatitis following chlorothiazide administration in pregnancy. Obstet Gynecol 1964; 24: 337–341
   PubMed Web of Science ®Google Scholar
• Schifrin B S, Spellacy W N, Little W A. Maternal death associated with excessive ingestion of a chlorothiazide diuretic. Obstet Gynecol 1969; 34: 215–220
   PubMed Web of Science ®Google Scholar
• Gjonnaess H. Thiazide treatment in pregnancy. Acta Obstet Gynaecol Scand 1968; 47: 404–419
   PubMed Web of Science ®Google Scholar
• Pritchard J A, Walley P J. Severe hypokalemia due to prolonged administration of chlorothiazide during pregnancy. Am J Obstet Gynecol 1961; 81: 1241–1244
   PubMed Web of Science ®Google Scholar
• Jouppila R, Jouppila P, Hollmen A. Laryngeal oedema as an obstetric anaesthesia complication: case reports. Acta Anaesth Scand 1980; 24: 97–98
   PubMed Web of Science ®Google Scholar
• Hans S F, Kopelman H. Methyldopa in treatment of severe toxaemia of pregnancy. Br Med J 1964; 1: 736–739
   PubMedGoogle Scholar
• Kincaid-Smith P, Bullen M, Mills J. Prolonged use of methyldopa in severe hypertension in pregnancy. Br Med J 1966; 1: 274–276
   PubMedGoogle Scholar
• Leather H M, Humphreys D M, Baker P, et al. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet 1968; 2: 488–490
   PubMed Web of Science ®Google Scholar
• Redman C WG, Beilin L J, Bonnar J, et al. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976; 2: 753–756
   PubMed Web of Science ®Google Scholar
• Redman C WG, Beilin W, Bonnar J. Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects. Br J Obstet Gynaecol 1977; 84: 419–429
   PubMedGoogle Scholar
• Redman C WG, Beilin L J, Bonnar J. Renal function in pre-eclampsia. J Clin Path (Suppl) 1976; 10: 91–94
   Google Scholar
• Silverstone A, Trudinger B J, Lewis P J, et al. Maternal hypertension and intrauterine fetal death in mid-pregnancy. Br J Obstet Gynecol 1980; 87: 457–461
   PubMedGoogle Scholar
• Mutch L MM, Moar V A, Ounsted M K, et al. Hypertension during pregnancy, with and without specific hypotensive treatment. I. Perinatal factors and neonatal morbidity. Early Human Develop 1977; 1: 47–57
   PubMed Web of Science ®Google Scholar
• Mutch L MM, Moar V A, Ounsted M K, et al. Hypertension during pregnancy, with and without specific hypotension treatment. II. The growth and development of the infant in the first year of life. Early Human Develop 1977; 1: 59–67
   PubMed Web of Science ®Google Scholar
• Moar V A, Jefferies M A, Mutch L MM, et al. Neonatal head circumference and the treatment of maternal hypertension. Br J Obstet Gynaecol 1978; 85: 933–937
   PubMedGoogle Scholar
• Ounsted M K, Moar V A, Good F J, et al. Hypertension during pregnancy with and without specific treatment; the children at the age of 4 years. Br J Obstet Gynaecol 1980; 87: 19–24
   PubMedGoogle Scholar
• Cockburn J, Moar V A, Ounsted M, et al. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982; i: 647–649
   Google Scholar
• Jones H MR, Cummings A J. A study of the transfer of -methyldopa to the hyman fetus and newborn infant. Br J Clin Pharmacol 1978; 6: 432–434
   PubMed Web of Science ®Google Scholar
• Whitelaw A. Maternal methyldopa treatment and neonatal blood pressure. Br Med J 1981; 283: 471
   PubMedGoogle Scholar
• Bodis J, Sulyok E, Ertl T, et al. Methyldopa in pregnancy hypertension and the newborn. Lancet 1982; 2: 498–499
   PubMed Web of Science ®Google Scholar